Covid-19 Impact on Biological Implants Market:
The ongoing COVID-19 pandemic conditions have severely affected every sector around the world. Whereas, the chemicals and materials sectors were moderately affected during the pandemic. This is primarily due to the uncut demand for chemicals for healthcare, life science, and cleaning agents. However, other elements of chemical and material sectors such as paints, industrial oil, and construction materials are facing a diminution in demand. Strict lockdown resulted in a nearly 50-60% reduction in the supply of raw materials, which directly affected the manufacturing process. Further, the halt in many end-use industries directly affected the chemical demand all around the world.
Biological Implants Market Overview
The Global Biological Implants Market was worth $118.6 billion in 2021 and is predicted to be worth $136.2 million by 2030, growing at a 10.12% CAGR from 2023 to 2030.
Biological implants are broadly used in organ transplantation and the replacement of tissues. The global biological implants market is mainly driven by rapid improvement in healthcare infrastructure in developed as well as developing regions. In addition, the increasing prevalence of chronic diseases such as cardiovascular diseases, osteoarthritis, and congenital and neuropathic disorders boosts the demand for biological implants. Globally, the ageing population is increasing rapidly. A large part of the ageing population needs dental implants which further boosts the demand for biological implants. Furthermore, developments in bioengineering technologies and increased awareness about cosmetic implants drive the growth of the biological implants market.
On the other hand, the high cost of biological implants acts as a barrier to the growth of the market. However, continuous technological advancement in the manufacturing of bio-implants such as 3D printing, nanotechnology, and laser technology. Also, rising government funding in the healthcare sector is expected to provide significant opportunities for market development during the forecast period.
Biological Implants Market Segment Overview
Dental implants are one of the leading contributors to the growth of the biological implants market. An increasing number of dental patients are selecting dental implants. It is an easier and more effective alternative to a root canal procedure. An awful increase in oral healthcare problems will further stimulate demand for dental implants. The Global Burden of Disease Study 2017 estimated that oral diseases affect close to 3.5 billion people worldwide, with caries of permanent teeth being the most common condition. Globally, it is estimated that 2.3 billion people suffer from caries of permanent teeth and more than 530 million children suffer from caries of primary teeth. This will provide huge growth opportunities for the market in the near future.
Biological Implants Market Regional Overview
North America holds a dominant position in the market. Some important factors such as increasing healthcare expenditure, technological advancement, and rising demand for nonsurgical bio-implants. Similarly, improved healthcare infrastructure in this region contributes towards market growth. Additionally, the market of the Asia Pacific is projected to grow at the fastest rate over the forecast period. An increased government funding for the healthcare sector and growth in economies in developing countries, such as India and China, is anticipated to drive the biological implants market in Asia.
Biological Implants Market Competitor Overview
Companies are engrossed in collaborations, mergers & acquisitions to improve their market share. For instance, in March 2018, Orthofix International N.V. acquired Spinal Kinetics Inc., a privately held manufacturer and developer of lumbar discs and artificial cervical. The move was aimed at strengthening Orthofix’s orthobiologics bio-implant product portfolio.
Biological Implants Market, Key Players
· Tornier N.V.
· Biomet, Inc.
· Smith & Nephew
· Boston Scientific Corporation
· Stryker Corporation,
· St. Jude Medical, Inc.
· Synthes Holding AG
· Medtronic
· DePuy Synthes
· Zimmer Biomet
· Organogenesis, Inc.
· Arthrex, Inc.
· Orthofix Holdings, Inc.
· Cochlear Ltd.
· Exactech, Inc.
Biological Implants Market Segmentation
Biological Implants Market, By Product
· Ceramics
· Polymers
· Alloys
· Biomaterial Metal
Biological Implants Market, By Origin
· Autograft
· Allograft
· Xenograft
· Synthetic
Biological Implants Market, By End-use
· Hospitals
· Clinics
· Specialty Centers
Biological Implants Market, By Region
The ongoing COVID-19 pandemic conditions have severely affected every sector around the world. Whereas, the chemicals and materials sectors were moderately affected during the pandemic. This is primarily due to the uncut demand for chemicals for healthcare, life science, and cleaning agents. However, other elements of chemical and material sectors such as paints, industrial oil, and construction materials are facing a diminution in demand. Strict lockdown resulted in a nearly 50-60% reduction in the supply of raw materials, which directly affected the manufacturing process. Further, the halt in many end-use industries directly affected the chemical demand all around the world.
Biological Implants Market Overview
The Global Biological Implants Market was worth $118.6 billion in 2021 and is predicted to be worth $136.2 million by 2030, growing at a 10.12% CAGR from 2023 to 2030.
Biological implants are broadly used in organ transplantation and the replacement of tissues. The global biological implants market is mainly driven by rapid improvement in healthcare infrastructure in developed as well as developing regions. In addition, the increasing prevalence of chronic diseases such as cardiovascular diseases, osteoarthritis, and congenital and neuropathic disorders boosts the demand for biological implants. Globally, the ageing population is increasing rapidly. A large part of the ageing population needs dental implants which further boosts the demand for biological implants. Furthermore, developments in bioengineering technologies and increased awareness about cosmetic implants drive the growth of the biological implants market.
On the other hand, the high cost of biological implants acts as a barrier to the growth of the market. However, continuous technological advancement in the manufacturing of bio-implants such as 3D printing, nanotechnology, and laser technology. Also, rising government funding in the healthcare sector is expected to provide significant opportunities for market development during the forecast period.
Biological Implants Market Segment Overview
Dental implants are one of the leading contributors to the growth of the biological implants market. An increasing number of dental patients are selecting dental implants. It is an easier and more effective alternative to a root canal procedure. An awful increase in oral healthcare problems will further stimulate demand for dental implants. The Global Burden of Disease Study 2017 estimated that oral diseases affect close to 3.5 billion people worldwide, with caries of permanent teeth being the most common condition. Globally, it is estimated that 2.3 billion people suffer from caries of permanent teeth and more than 530 million children suffer from caries of primary teeth. This will provide huge growth opportunities for the market in the near future.
Biological Implants Market Regional Overview
North America holds a dominant position in the market. Some important factors such as increasing healthcare expenditure, technological advancement, and rising demand for nonsurgical bio-implants. Similarly, improved healthcare infrastructure in this region contributes towards market growth. Additionally, the market of the Asia Pacific is projected to grow at the fastest rate over the forecast period. An increased government funding for the healthcare sector and growth in economies in developing countries, such as India and China, is anticipated to drive the biological implants market in Asia.
Biological Implants Market Competitor Overview
Companies are engrossed in collaborations, mergers & acquisitions to improve their market share. For instance, in March 2018, Orthofix International N.V. acquired Spinal Kinetics Inc., a privately held manufacturer and developer of lumbar discs and artificial cervical. The move was aimed at strengthening Orthofix’s orthobiologics bio-implant product portfolio.
Biological Implants Market, Key Players
· Tornier N.V.
· Biomet, Inc.
· Smith & Nephew
· Boston Scientific Corporation
· Stryker Corporation,
· St. Jude Medical, Inc.
· Synthes Holding AG
· Medtronic
· DePuy Synthes
· Zimmer Biomet
· Organogenesis, Inc.
· Arthrex, Inc.
· Orthofix Holdings, Inc.
· Cochlear Ltd.
· Exactech, Inc.
Biological Implants Market Segmentation
Biological Implants Market, By Product
- Cardiovascular Implants
- Pacing Devices
- Pacemaker
- ICDs
- Stents
- Pacing Devices
- Orthopedic Implants
- Orthobiologics
- Trauma Implants
- Hip Replacements
- Knee Replacements
- Spinal Implants
- Dental Implants
- Ophthalmic Implants
- Others
· Ceramics
· Polymers
· Alloys
· Biomaterial Metal
Biological Implants Market, By Origin
· Autograft
· Allograft
· Xenograft
· Synthetic
Biological Implants Market, By End-use
· Hospitals
· Clinics
· Specialty Centers
Biological Implants Market, By Region
- North America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Biological Implants Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Product
- 5.2.1. Cardiovascular Implants
- 5.2.1.1. Pacing Devices
- 5.2.1.1.1. Pacemaker
- 5.2.1.1.2. ICDs
- 5.2.1.2. Stents
- 5.2.1.1. Pacing Devices
- 5.2.2. Orthopedic Implants
- 5.2.2.1. Orthobiologics
- 5.2.2.2. Trauma Implants
- 5.2.2.3. Hip Replacements
- 5.2.2.4. Knee Replacements
- 5.2.3. Spinal Implants
- 5.2.4. Dental Implants
- 5.2.5. Ophthalmic Implants
- 5.2.6. Others
- 5.2.1. Cardiovascular Implants
- 5.3. Market Analysis, Insights and Forecast – By Material
- 5.3.1. Ceramics
- 5.3.2. Polymers
- 5.3.3. Alloys
- 5.3.4. Biomaterial Metal
- 5.4. Market Analysis, Insights and Forecast – By Origin
- 5.4.1. Autograft
- 5.4.2. Allograft
- 5.4.3. Xenograft
- 5.4.4. Synthetic
- 5.5. Market Analysis, Insights and Forecast – By End-use
- 5.5.1. Hospitals
- 5.5.2. Clinics
- 5.5.3. Specialty Centers
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Latin America
- 5.6.3. Europe
- 5.6.4. Asia Pacific
- 5.6.5. Middle East and Africa
6. North America Biological Implants Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Product
- 6.2.1. Cardiovascular Implants
- 6.2.1.1. Pacing Devices
- 6.2.1.1.1. Pacemaker
- 6.2.1.1.2. ICDs
- 6.2.1.2. Stents
- 6.2.1.1. Pacing Devices
- 6.2.2. Orthopedic Implants
- 6.2.2.1. Orthobiologics
- 6.2.2.2. Trauma Implants
- 6.2.2.3. Hip Replacements
- 6.2.2.4. Knee Replacements
- 6.2.3. Spinal Implants
- 6.2.4. Dental Implants
- 6.2.5. Ophthalmic Implants
- 6.2.6. Others
- 6.2.1. Cardiovascular Implants
- 6.3. Market Analysis, Insights and Forecast – By Material
- 6.3.1. Ceramics
- 6.3.2. Polymers
- 6.3.3. Alloys
- 6.3.4. Biomaterial Metal
- 6.4. Market Analysis, Insights and Forecast – By Origin
- 6.4.1. Autograft
- 6.4.2. Allograft
- 6.4.3. Xenograft
- 6.4.4. Synthetic
- 6.5. Market Analysis, Insights and Forecast – By End-use
- 6.5.1. Hospitals
- 6.5.2. Clinics
- 6.5.3. Specialty Centers
- 6.6. Market Analysis, Insights and Forecast – By Country
- 6.6.1. U.S.
- 6.6.2. Canada
7. Latin America Biological Implants Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Product
- 7.2.1. Cardiovascular Implants
- 7.2.1.1. Pacing Devices
- 7.2.1.1.1. Pacemaker
- 7.2.1.1.2. ICDs
- 7.2.1.2. Stents
- 7.2.1.1. Pacing Devices
- 7.2.2. Orthopedic Implants
- 7.2.2.1. Orthobiologics
- 7.2.2.2. Trauma Implants
- 7.2.2.3. Hip Replacements
- 7.2.2.4. Knee Replacements
- 7.2.3. Spinal Implants
- 7.2.4. Dental Implants
- 7.2.5. Ophthalmic Implants
- 7.2.6. Others
- 7.2.1. Cardiovascular Implants
- 7.3. Market Analysis, Insights and Forecast – By Material
- 7.3.1. Ceramics
- 7.3.2. Polymers
- 7.3.3. Alloys
- 7.3.4. Biomaterial Metal
- 7.4. Market Analysis, Insights and Forecast – By Origin
- 7.4.1. Autograft
- 7.4.2. Allograft
- 7.4.3. Xenograft
- 7.4.4. Synthetic
- 7.5. Market Analysis, Insights and Forecast – By End-use
- 7.5.1. Hospitals
- 7.5.2. Clinics
- 7.5.3. Specialty Centers
- 7.6. Market Analysis, Insights and Forecast – By Country
- 7.6.1. Brazil
- 7.6.2. Mexico
- 7.6.3. Rest of Latin America
8. Europe Biological Implants Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Product
- 8.2.1. Cardiovascular Implants
- 8.2.1.1. Pacing Devices
- 8.2.1.1.1. Pacemaker
- 8.2.1.1.2. ICDs
- 8.2.1.2. Stents
- 8.2.1.1. Pacing Devices
- 8.2.2. Orthopedic Implants
- 8.2.2.1. Orthobiologics
- 8.2.2.2. Trauma Implants
- 8.2.2.3. Hip Replacements
- 8.2.2.4. Knee Replacements
- 8.2.3. Spinal Implants
- 8.2.4. Dental Implants
- 8.2.5. Ophthalmic Implants
- 8.2.6. Others
- 8.2.1. Cardiovascular Implants
- 8.3. Market Analysis, Insights and Forecast – By Material
- 8.3.1. Ceramics
- 8.3.2. Polymers
- 8.3.3. Alloys
- 8.3.4. Biomaterial Metal
- 8.4. Market Analysis, Insights and Forecast – By Origin
- 8.4.1. Autograft
- 8.4.2. Allograft
- 8.4.3. Xenograft
- 8.4.4. Synthetic
- 8.5. Market Analysis, Insights and Forecast – By End-use
- 8.5.1. Hospitals
- 8.5.2. Clinics
- 8.5.3. Specialty Centers
- 8.6. Market Analysis, Insights and Forecast – By Country
- 8.6.1. UK
- 8.6.2. Germany
- 8.6.3. France
- 8.6.4. Italy
- 8.6.5. Spain
- 8.6.6. Russia
- 8.6.7. Rest of Europe
9. Asia Pacific Biological Implants Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Product
- 9.2.1. Cardiovascular Implants
- 9.2.1.1. Pacing Devices
- 9.2.1.1.1. Pacemaker
- 9.2.1.1.2. ICDs
- 9.2.1.2. Stents
- 9.2.1.1. Pacing Devices
- 9.2.2. Orthopedic Implants
- 9.2.2.1. Orthobiologics
- 9.2.2.2. Trauma Implants
- 9.2.2.3. Hip Replacements
- 9.2.2.4. Knee Replacements
- 9.2.3. Spinal Implants
- 9.2.4. Dental Implants
- 9.2.5. Ophthalmic Implants
- 9.2.6. Others
- 9.2.1. Cardiovascular Implants
- 9.3. Market Analysis, Insights and Forecast – By Material
- 9.3.1. Ceramics
- 9.3.2. Polymers
- 9.3.3. Alloys
- 9.3.4. Biomaterial Metal
- 9.4. Market Analysis, Insights and Forecast – By Origin
- 9.4.1. Autograft
- 9.4.2. Allograft
- 9.4.3. Xenograft
- 9.4.4. Synthetic
- 9.5. Market Analysis, Insights and Forecast – By End-use
- 9.5.1. Hospitals
- 9.5.2. Clinics
- 9.5.3. Specialty Centers
- 9.6. Market Analysis, Insights and Forecast – By Country
- 9.6.1. China
- 9.6.2. India
- 9.6.3. Japan
- 9.6.4. Australia
- 9.6.5. South East Asia
- 9.6.6. Rest of Asia Pacific
10. Middle East & Africa Biological Implants Market Analysis (USD Billion), Insights and Forecast, 2023-2030
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Product
- 10.2.1. Cardiovascular Implants
- 10.2.1.1. Pacing Devices
- 10.2.1.1.1. Pacemaker
- 10.2.1.1.2. ICDs
- 10.2.1.2. Stents
- 10.2.1.1. Pacing Devices
- 10.2.2. Orthopedic Implants
- 10.2.2.1. Orthobiologics
- 10.2.2.2. Trauma Implants
- 10.2.2.3. Hip Replacements
- 10.2.2.4. Knee Replacements
- 10.2.3. Spinal Implants
- 10.2.4. Dental Implants
- 10.2.5. Ophthalmic Implants
- 10.2.6. Others
- 10.2.1. Cardiovascular Implants
- 10.3. Market Analysis, Insights and Forecast – By Material
- 10.4. Ceramics
- 10.5. Polymers
- 10.6. Alloys
- 10.7. Biomaterial Metal
- 10.8. Market Analysis, Insights and Forecast – By Origin
- 10.8.1. Autograft
- 10.8.2. Allograft
- 10.8.3. Xenograft
- 10.8.4. Synthetic
- 10.9. Market Analysis, Insights and Forecast – By End-use
- 10.9.1. Hospitals
- 10.9.2. Clinics
- 10.9.3. Specialty Centers
- 10.10. Market Analysis, Insights and Forecast – By Country
- 10.10.1. GCC
- 10.10.2. South Africa
- 10.10.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Company Market Share Analysis, 2021
- 11.2. Key Industry Developments
- 11.3. Company Profile
- 11.4. Tornier N.V.
- 11.4.1. Business Overview
- 11.4.2. Segment 1 & Service Offering
- 11.4.3. Overall Revenue
- 11.4.4. Geographic Presence
- 11.4.5. Recent Development
- 11.5. Biomet, Inc.
- 11.6. Smith & Nephew
- 11.7. Boston Scientific Corporation
- 11.8. Stryker Corporation,
- 11.9. St. Jude Medical, Inc.
- 11.10. Synthes Holding AG
- 11.11. Medtronic
- 11.12. DePuy Synthes
- 11.13. Zimmer Biomet
- 11.14. Organogenesis, Inc.
- 11.15. Arthrex, Inc.
- 11.16. Orthofix Holdings, Inc.
- 11.17. Cochlear Ltd.
Research Process
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
